Recurrent Laryngeal Verrucous Carcinoma

7 clinical trials · Condition

Record	Firm	Date
Interstitial Photodynamic Therapy in Treating Patients With Recurrent Head and Neck Cancer (NCT02068157)	Roswell Park Cancer Institute	2014-04-01
Cisplatin With or Without WEE1 Inhibitor MK-1775 in Treating Patients With Recurrent or Metastatic Head and Neck Cancer (NCT02196168)	National Cancer Institute (NCI)	2014-03-01
Lenalidomide and Cetuximab in Treating Patients With Advanced Colorectal Cancer or Head and Neck Cancer (NCT01254617)	National Cancer Institute (NCI)	2011-02-10
Temsirolimus With or Without Cetuximab in Patients With Recurrent and/or Metastatic Head and Neck Cancer Who Did Not Respond to Previous Therapy (NCT01256385)	National Cancer Institute (NCI)	2010-11-01
Soy Isoflavones in Preventing Head and Neck Cancer Recurrence in Patients With Stage I-IV Head and Neck Cancer Undergoing Surgery (NCT02007200)	National Cancer Institute (NCI)	2009-07-01
Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (NCT00588770)	National Cancer Institute (NCI)	2008-08-08
Cediranib Maleate in Treating Patients With Recurrent or Newly Diagnosed Metastatic Head and Neck Cancer (NCT00458978)	National Cancer Institute (NCI)	2007-02-01

Every clearance here is in the API, with alerts when new ones post.